Fig. 1From: Pharmacogenomic study on anti-VEGF medicine in treatment of macular Neovascular diseases: a study protocol for a prospective observational studyFlowchart of recruitment and observation procedures of this study. 1 m, 3 m,6 m, and 12 m means 1 month, 3 months, 6 months, and 12 months after Conbercept treatmentBack to article page